|Nom||Titre||Payer||Exercé||Année de naissance|
|Mr. Herve Duchesne de Lamotte||CFO, GM & Member of the Management Board||S.O.||S.O.||1959|
|Mr. Jean-Michel Carle Grandmougin||Pres of the Management Board||S.O.||S.O.||S.O.|
|Mr. Denis Fortier||GM & Member of the Management Board||S.O.||S.O.||S.O.|
|Mr. Jacques Martin Ph.D.||VP of Marketing||S.O.||S.O.||S.O.|
|Mr. Thomas Iff||Chief Bus. Officer||S.O.||S.O.||S.O.|
Eurobio Scientific SociÃ©tÃ© anonyme discovers and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific SociÃ©tÃ© anonyme in June 2018. Eurobio Scientific SociÃ©tÃ© anonyme was founded in 1997 and is headquartered in Les Ulis, France.
L’ISS Governance QualityScore de Eurobio Scientific Société anonyme en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..